申请人:Mutabilis
公开号:EP2141164A1
公开(公告)日:2010-01-06
The invention relates to new 1,2,4-triazine derivatives of formula (I):
wherein A, B, R2 and Y are defined in the application,
their preparation and intermediates, their use as drugs and pharmaceutical compositions and associations containing them.
The compounds of formula (I) are capable of inhibiting bacterial heptose synthesis.
这项发明涉及公式(I)的新1,2,4-三嗪衍生物:
其中A、B、R2和Y在申请中有定义,
它们的制备和中间体,它们作为药物和药物组合物的用途以及含有它们的关联物。
公式(I)的化合物能够抑制细菌七糖合成。